Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05360238
Title Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mustang Bio
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC Irvine Health - Chao Family Comprehensive Cancer Center Orange California 92868-3201 United States Details
Massachusetts General Hospital (MGH) Boston Massachusetts 02114 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Rochester Medical Center Rochester New York 14642 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field